The Effectiveness of COVID-19 Testing and Contact Tracing in a US City
Overview
Authors
Affiliations
Although testing, contact tracing, and case isolation programs can mitigate COVID-19 transmission and allow the relaxation of social distancing measures, few countries worldwide have succeeded in scaling such efforts to levels that suppress spread. The efficacy of test-trace-isolate likely depends on the speed and extent of follow-up and the prevalence of SARS-CoV-2 in the community. Here, we use a granular model of COVID-19 transmission to estimate the public health impacts of test-trace-isolate programs across a range of programmatic and epidemiological scenarios, based on testing and contact tracing data collected on a university campus and surrounding community in Austin, TX, between October 1, 2020, and January 1, 2021. The median time between specimen collection from a symptomatic case and quarantine of a traced contact was 2 days (interquartile range [IQR]: 2 to 3) on campus and 5 days (IQR: 3 to 8) in the community. Assuming a reproduction number of 1.2, we found that detection of 40% of all symptomatic cases followed by isolation is expected to avert 39% (IQR: 30% to 45%) of COVID-19 cases. Contact tracing is expected to increase the cases averted to 53% (IQR: 42% to 58%) or 40% (32% to 47%), assuming the 2- and 5-day delays estimated on campus and in the community, respectively. In a tracing-accelerated scenario, in which 75% of contacts are notified the day after specimen collection, cases averted increase to 68% (IQR: 55% to 72%). An accelerated contact tracing program leveraging rapid testing and electronic reporting of test results can significantly curtail local COVID-19 transmission.
Wang Z, Yang P, Wang R, Ferretti L, Zhao L, Pei S Nat Commun. 2024; 15(1):6103.
PMID: 39030231 PMC: 11271501. DOI: 10.1038/s41467-024-50487-7.
Mongin D, Burgisser N, Courvoisier D Euro Surveill. 2024; 29(3).
PMID: 38240059 PMC: 10797663. DOI: 10.2807/1560-7917.ES.2024.29.3.2300228.
Ozdenerol E, Bingham-Byrne R, Seboly J Int J Environ Res Public Health. 2023; 20(21).
PMID: 37947579 PMC: 10649683. DOI: 10.3390/ijerph20217023.
Lau B, Wentz E, Ni Z, Yenokyan K, Vergara C, Mehta S Am J Med. 2023; 138(2):287-297.e21.
PMID: 37690503 PMC: 10924070. DOI: 10.1016/j.amjmed.2023.08.009.
Effects of public-health measures for zeroing out different SARS-CoV-2 variants.
Ge Y, Wu X, Zhang W, Wang X, Zhang D, Wang J Nat Commun. 2023; 14(1):5270.
PMID: 37644012 PMC: 10465600. DOI: 10.1038/s41467-023-40940-4.